Diabetes drug shows benefits for patients with liver disease

Last updated: June 30, 2025 9:26 am

0 Min Read

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical trial from China published by The BMJ…

Leave a Reply Cancel reply

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

Refresh Screen

Ads Blocker Detected & This Is Prohibited!!!

Refresh Screen

Top Stories

‘Brainspotting’ Was Life-Changing for Me. Here’s What to Know About the New-ish Therapy Technique

Liverpool expect player to leave this summer amid interest from Euro giants

Man United make offer to former Manchester City defender, Chelsea also keen

Stay Connected

Diabetes drug shows benefits for patients with liver disease

Leave a Reply Cancel reply

Related Stories

‘Brainspotting’ Was Life-Changing for Me. Here’s What to Know About the New-ish Therapy Technique

Disparities in Myasthenia Gravis Care

The Best Weight Bench to Add to Your Home Gym in 2025

HELP Committee Supports Reauthorizing FDA Program to Streamline Review of OTC Drugs

Texas Hospital That Discharged Woman With Doomed Pregnancy Violated Law, Probe Finds

Viral Immunotherapy Reduces Recurrences in Early Prostate Cancer

Antibiotics taken during pregnancy may reduce preterm births

Recent diphtheria epidemic in Western Europe traced to migration routes, not countries of origin